NIFTY 50 22795.9 ▼ (0.51%)
NIFTY NEXT 50 60466.8 ▼ (0.94%)
NIFTY 100 23274.05 ▼ (0.59%)
NIFTY MIDCAP 100 50486.2 ▼ (1.32%)
NIFTY SMALLCAP 100 15636.9 ▼ (0.7%)
NIFTY SMALLCAP 250 14683.4 ▼ (0.57%)
NIFTY MIDCAP SELECT 11198.9 ▼ (1.69%)
NIFTY TOTAL MARKET 11634.25 ▼ (0.67%)
NIFTY BANK 48981.2 ▼ (0.72%)
SENSEX 75311.06 ▼ (0.56%)
BSE BANKEX 55718.18 ▼ (0.82%)

REMEDIUM LIFECARE : Q4 2024 Financial Quarterly Report : YoY Sales Up 1763.58 %, QoQ Down 23.21 %

June 25, 2024June 25, 2024| adminadmin| 0 Comments| 3:05 pm
Image is loading
Categories:

Share the post "REMEDIUM LIFECARE : Q4 2024 Financial Quarterly Report : YoY Sales Up 1763.58 %, QoQ Down 23.21 %"

  • Facebook
  • LinkedIn
  • X
  • Tumblr
  • WhatsApp
  • TelegramTelegram
  • Email

Highlights

  • Sales over the Year and quarter: The company experienced a substantial growth of 1763.58 % in the past year, decrease in net sales/revenue by -23.21 %.
  • Income over the Year and quarter: Marginal decrease of -79.53% in other income during this quarter.
  • Profit over the Year and quarter: Significant improvement in profitability for REMEDIUM LIFECARE LIMITED. Notable increase of 1023.64 % in net profit Year to Year, REMEDIUM LIFECARE LIMITED’s profitability dropped by -178.11 % Quarter to Quarter.
  • EPS over the Year and quarter: EPS declined by -135.37 % Year to Year. EPS decreased by -115.62 % in previous quarter. Analysis needed for shareholder value.

The comprehensive analytics outlining the performance and outlook of REMEDIUM LIFECARE LIMITED”s stock. This analysis encompasses various metrics including stock performance, investor sentiment, market trends, future outlook, risk factors, investment opportunities, long-term strategy, dividend policy, analyst insights, and the overall risk-reward profile. These insights aim to provide investors with a holistic understanding of the company”s stock, enabling informed decision-making and strategic investment planning.

Metrics Previous Year Previous Quarter Current Quarter Quarter to Quarter Difference Year to Year Difference
Sales Rs. 75.58 Cr Rs. 1834.178 Cr Rs. 1408.494 Cr -23.21 % + 1763.58 %
Expenses Rs. 78.28 Cr Rs. 1779.47 Cr Rs. 1443.52 Cr -18.88 % + 1744.05 %
Operating Profit Rs. -2.7 Cr Rs. 54.71 Cr Rs. -35.03 Cr -164.03 % -1197.41 %
OPM % -3.57 % 2.98 % -2.49 % -5.47 % + 1.08 %
Other Income Rs. 0 Cr Rs. 14.12 Cr Rs. 2.89 Cr -79.53 % 0 %
Interest Rs. 0.1 Cr Rs. 0.03 Cr Rs. 3.85 Cr + 12733.33 % + 3750 %
Depreciation Rs. 0.01 Cr Rs. 0.01 Cr Rs. 0.01 Cr + 0 % + 0 %
Profit before tax Rs. -2.81 Cr Rs. 68.79 Cr Rs. -36 Cr -152.33 % -1181.14 %
Tax % -70.08 % 0 % -49.24 % -49.24 % + 20.84 %
Net Profit Rs. -4.78 Cr Rs. 68.78 Cr Rs. -53.72 Cr -178.1 % -1023.85 %
EPS in Rs Rs. -15.07 Rs. 34.12 Rs. -5.33 -115.62 % + 64.63 %


Today, we’re looking at REMEDIUM LIFECARE LIMITED’s financial performance for the Q4(Mar 2024).Starting with the top line, the company reported a robust year-over-year sales growth of 1763.58 %. However, it did see a marginal slip of -23.21 % from the previous quarter. Expenses decreased slightly by -18.88 % quarter-on-quarter, aligning with the annual rise of 1744.05 %. Operating profit, while down -1197.41 % compared to last year, faced a quarter-on-quarter dip of -164.03 %, signaling a short-term contraction in margins.
The Operating Profit Margin (OPM) % echoes this narrative, showing resilience on an annual basis with an increase of 1.08 %, but a shrinkage of -5.47 % sequentially. Other income fell by -79.53 % compared to the last quarter, Interest expenses surged remarkably by 12733.33 % from the previous quarter, yet the year-over-year increase remains at a moderate 3750 %. Depreciation costs climbed by 0 % quarter-on-quarter, whereas on an annual scale, they saw an increase of 0 %. Profit before tax declined annually by -1181.14 % but saw a reduction from the preceding quarter by -152.33 %.
Tax expenses as a percentage of profits increased slightly by 20.84 % compared to last year, with a more notable quarter-on-quarter decrease of -49.24 %. Net profit fell by -1023.85 % year-on-year but witnessed a -178.1 % contraction from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 64.63 % but a quarterly fall of -115.62 %. In summary, REMEDIUM LIFECARE LIMITED’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.

Metrics Previous Year Previous Quarter Current Quarter Quarter to Quarter Difference Year to Year Difference
Sales Rs. 75.58 Cr Rs. 1834.178 Cr Rs. 1408.494 Cr -23.21 % + 1763.58 %
Expenses Rs. 78.28 Cr Rs. 1779.47 Cr Rs. 1443.52 Cr -18.88 % + 1744.05 %
Operating Profit Rs. -2.7 Cr Rs. 54.71 Cr Rs. -35.03 Cr -164.03 % -1197.41 %
Net Profit Rs. -4.78 Cr Rs. 68.78 Cr Rs. -53.72 Cr -178.1 % -1023.85 %
EPS in Rs Rs. -15.07 Rs. 34.12 Rs. -5.33 -115.62 % + 64.63 %


In reviewing REMEDIUM LIFECARE LIMITED’s 2024(Q4) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 1763.58 % year-on-year growth, although there was a slight dip of -23.21 % from the previous quarter. Expenses rose by 1744.05 % compared to the previous year, with a decrease of -18.88 % quarter-on-quarter. Operating Profit dropped by -1197.41 % annually, and saw a -164.03 % decrease from the last quarter.
Net Profit showed yearly decrease of -1023.85 %, and experienced a -178.1 % decrease from the previous quarter. Earnings Per Share (EPS) rose by 64.63 % annually, however dipped by -115.62 % compared to the last quarter. In essence, while REMEDIUM LIFECARE LIMITED faces strong annual decline indicators, short-term fluctuations suggest the need for agile strategies to navigate market dynamics effectively. That’s all for now in the financial sector.

[my_shortcode1 values=”REMEDIUM LIFECARE “]

Related Post